---
name: Copy Farallon Capital Management
kind: hedgecopy-fund
cik: 0000909661
latest_13f_period: 2026-06-30
latest_13f_filed: 2026-08-14
author: HedgeCopy
---

# Copy Farallon Capital Management (13F follow-the-filing)

Farallon Capital Management files a 13F-HR with the SEC each quarter (CIK 0000909661). This skill describes a
long-only copy portfolio built from that filing, bought the trading day after it is filed.

## Track record (estimated from 13F holdings, net of 10 bps per unit of turnover)
- Annualised return copying the filings, last 3 years (headline): +22.8% vs SPY +22.9% (alpha -0.1%/yr)
- Annualised since the series started (2022-08-19 to 2026-10-09): +16.4% vs SPY +17.3%
- Follow-the-filing TTM: +24.4% vs SPY +16.2% (alpha +8.2%)
- Quarters of history: 17; average coverage 80%; flags: hard_to_copy

## Latest disclosed top holdings (2026-06-30)
| # | Ticker | Issuer | Weight |
|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 15.0% |
| 2 | — | ELECTRONIC ARTS INC | 9.6% |
| 3 | BBIO | BRIDGEBIO PHARMA INC | 4.7% |
| 4 | PTGX | PROTAGONIST THERAPEUTICS INC | 4.6% |
| 5 | EXEL | EXELIXIS INC | 4.3% |
| 6 | LQDA | LIQUIDIA CORPORATION | 3.9% |
| 7 | AMZN | AMAZON COM INC | 3.7% |
| 8 | LNTH | LANTHEUS HLDGS INC | 3.7% |
| 9 | NTRA | NATERA INC | 3.6% |
| 10 | UNH | UNITEDHEALTH GROUP INC | 3.1% |
| 11 | TMO | THERMO FISHER SCIENTIFIC INC | 3.1% |
| 12 | — | ROIVANT SCIENCES LTD | 3.0% |
| 13 | — | AON PLC | 2.7% |
| 14 | BSX | BOSTON SCIENTIFIC CORP | 2.7% |
| 15 | AVGO | BROADCOM INC | 2.6% |
| 16 | MSFT | MICROSOFT CORP | 2.4% |
| 17 | TNGX | TANGO THERAPEUTICS INC | 2.3% |
| 18 | KKR | KKR & CO INC | 2.2% |
| 19 | SNPS | SYNOPSYS INC | 2.2% |
| 20 | BEAM | BEAM THERAPEUTICS INC | 2.1% |

## About the fund

Farallon Capital Management is an American multi-strategy investment firm headquartered in San Francisco. The firm manages capital for institutional and private investors, investing in public and private assets globally across a variety of strategies.

- Strategy: Multi-strategy, including credit, long/short equity, merger arbitrage, risk arbitrage, and real estate.
- Type: Multi-strategy
- Founders: Thomas Steyer
- Key people: Nicolas Giauque (Managing Partner); Andrew J.M. Spokes (Principal owner)
- Founded 1986 · HQ San Francisco, U.S.
- Reported AUM: $43.6bn (as of December 31, 2025)
- Website: https://www.faralloncapital.com/

### Approach
Farallon employs a bottom-up fundamental research and analysis approach, seeking global investment opportunities across public and private assets. The firm maintains flexible investment parameters, allowing capital to shift among strategies and asset classes based on prevailing opportunities and risk-adjusted returns. Risk is managed through rigorous analysis, portfolio-level analytics, and hedging techniques.

### History
Founded by Thomas Steyer in 1986, the firm initially focused on merger arbitrage. Over the decades, it expanded its strategies to include credit, real estate, and direct investments, and established a global presence with offices in cities including London, Singapore, Hong Kong, Tokyo, São Paulo, and New York. The firm underwent a leadership transition with the retirement of Thomas Steyer and the promotion of Andrew Spokes, followed by the appointment of Nicolas Giauque as Managing Partner in 2025.

### Notable positions / campaigns
- Bank Central Asia (2002): Farallon bought control of the Indonesian financial institution for $531 million and sold its stake for a profit in 2006.
- Mills Corp (2007): Farallon purchased the real estate investment trust in partnership with Simon Property Group and other hedge funds.
- Toshiba: Farallon was one of the largest shareholders in the Japanese electronics company.

_Profile generated 2026-10-09 from public sources; may be incomplete or out of date._

## Rules
- Hold the top 20 long US-equity positions from the latest 13F-HR, weighted as reported.
- Rebalance on the first trading day after each new 13F-HR is filed. Cash only, paper only.

## Parameters
```json
{
  "params": {
    "funds": [
      "0000909661"
    ],
    "top_n": 20,
    "weighting": "13f",
    "rebalance": "filing_plus_1",
    "budget_usd": 10000,
    "stop_loss_pct": null,
    "cash_only": true
  }
}
```

> Estimated from 13F holdings (long US equities only; no shorts, options, cash or fees). Past performance is not a guide to the future. Not investment advice. Paper trading only.